Earth Life Sciences Inc.
CLTS
$0.00
$0.000.00%
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -94.17% | 933.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -94.17% | 933.88% | |||
| Operating Income | 94.17% | -933.88% | |||
| Income Before Tax | 93.51% | -799.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 93.51% | -799.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 93.51% | -799.44% | |||
| EBIT | 94.17% | -933.88% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 100.00% | -- | |||
| Normalized Basic EPS | 100.00% | -- | |||
| EPS Diluted | 100.00% | -- | |||
| Normalized Diluted EPS | 100.00% | -- | |||
| Average Basic Shares Outstanding | -0.59% | 1.66% | |||
| Average Diluted Shares Outstanding | -0.59% | 1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
